Skip to Content

Eptifibatide

In the US, Eptifibatide (eptifibatide systemic) is a member of the drug class glycoprotein platelet inhibitors and is used to treat Acute Coronary Syndrome, Angina, Heart Attack and Percutaneous Coronary Intervention.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

B01AC16

CAS registry number (Chemical Abstracts Service)

0148031-34-9

Chemical Formula

C35-H49-N11-O9-S2

Molecular Weight

833

Therapeutic Category

Antiplatelet agent: Glycoprotein IIb/IIIa-receptor antagonist

Chemical Name

Cyclo(S-S)-mercaptopropionyl-(L) homoarginyl-glycyl-(L) aspartyl-(L) tryptophanyl-(L) prolyl-(L) cysteinamide

Foreign Names

  • Eptifibatidum (Latin)
  • Eptifibatid (German)
  • Eptifibatide (French)
  • Eptifibatida (Spanish)

Generic Names

  • Eptifibatide (OS: DCF, BAN)
  • C 6822 (IS)
  • Intrifiban (IS)
  • SB 1 (IS)
  • SCH 60936 (IS)

Brand Names

  • Clotide
    Biocon, India
  • Coromax
    USV, India
  • Eptifab
    AHPL, India
  • Eptifibatide Strides
    Agila, Bulgaria; Strides Arcolab, Poland
  • Eptifibatide Teva
    Teva, Israel
  • Integrilin
    Glaxo Group, Austria; Glaxo Group, Hungary; Glaxo Group, Iceland; Glaxo Group, Poland; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Spain; GlaxoSmithKline, Finland; GlaxoSmithKline, Greece; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Ireland; GlaxoSmithKline, Italy; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Norway; GlaxoSmithKline, Portugal; GlaxoSmithKline, Romania; GlaxoSmithKline, Serbia; GlaxoSmithKline, Slovakia; GlaxoSmithKline Laboratoire Pharmaceutique, France; GlaxoSmithKline UK, United Kingdom; GSK, Belgium; Merck, Canada; Merck Sharp & Dohme, Hong Kong; Merck Sharp & Dohme, New Zealand; MSD, Thailand; Schering, United States; Schering-Plough, Argentina; Schering-Plough, Indonesia; Schering-Plough, Israel; Schering-Plough, Taiwan; Schering-Plough, South Africa; Scherring, Egypt
  • INTEGRILIN
    GlaxoSmithKline, Sweden

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide